1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Zheng Y, Lv X, Wang X, Wang B, Shao X,
Huang Y, Shi L, Chen Z, Huang J and Huang P: MiR-181b promotes
chemoresistance in breast cancer by regulating Bim expression.
Oncol Rep. 35:683–690. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Liu S, Song L, Zeng S and Zhang L:
MALAT1-miR-124-RBG2 axis is involved in growth and invasion of
HR-HPV-positive cervical cancer cells. Tumour Biol. 37:633–640.
2016. View Article : Google Scholar : PubMed/NCBI
|
9
|
Yu B, Lv X, Su L, Wang B, Shao X, Huang Y,
Shi L, Chen Z, Huang J and Huang P: MiR-148a functions as a tumor
suppressor by targeting CCK-BR via inactivating STAT3 and Akt in
human gastric cancer. PLoS One. 11:e01589612016. View Article : Google Scholar : PubMed/NCBI
|
10
|
Xu X, Zhang Y, Jasper J, Lykken E,
Alexander PB, Markowitz GJ, McDonnell DP, Li QJ and Wang XF:
MiR-148a functions to suppress metastasis and serves as a
prognostic indicator in triple-negative breast cancer. Oncotarget.
7:20381–20394. 2016.PubMed/NCBI
|
11
|
Feng H, Wang Y, Su J, Liang H, Zhang CY,
Chen X and Yao W: MicroRNA-148a suppresses the proliferation and
migration of pancreatic cancer cells by down-regulating ErbB3.
Pancreas. 45:1263–1271. 2016. View Article : Google Scholar : PubMed/NCBI
|
12
|
Li L, Chen YY, Li SQ, Huang C and Qin YZ:
Expression of miR-148/152 family as potential biomarkers in
non-small-cell lung cancer. Med Sci Monit. 21:1155–1161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Joshi P, Jeon YJ, Lagana A, Middleton J,
Secchiero P, Garofalo M and Croce CM: MicroRNA-148a reduces
tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc
Natl Acad Sci USA. 112:8650–8655. 2015. View Article : Google Scholar : PubMed/NCBI
|
14
|
Li J, Yu T, Cao J, Liu L, Liu Y, Kong HW,
Zhu MX, Lin HC, Chu DD, Yao M and Yan MX: MicroRNA-148a suppresses
invasion and metastasis of human non-small-cell lung cancer. Cell
Physiol Biochem. 37:1847–1856. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
He M and Xue Y: MicroRNA-148a suppresses
proliferation and invasion potential of non-small cell lung
carcinomas via regulation of STAT3. Onco Targets Ther.
10:1353–1361. 2017. View Article : Google Scholar : PubMed/NCBI
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Gailhouste L, Gomez-Santos L, Hagiwara K,
Hatada I, Kitagawa N, Kawaharada K, Thirion M, Kosaka N, Takahashi
RU, Shibata T, et al: miR-148a plays a pivotal role in the liver by
promoting the hepatospecific phenotype and suppressing the
invasiveness of transformed cells. Hepatology. 58:1153–1165. 2013.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Xia J, Guo X, Yan J and Deng K: The role
of miR-148a in gastric cancer. J Cancer Res Clin Oncol.
140:1451–1456. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Heo MJ, Kim YM, Koo JH, Yang YM, An J, Lee
SK, Lee SJ, Kim KM, Park JW and Kim SG: microRNA-148a dysregulation
discriminates poor prognosis of hepatocellular carcinoma in
association with USP4 overexpression. Oncotarget. 5:2792–2806.
2014. View Article : Google Scholar : PubMed/NCBI
|
20
|
Zheng B, Liang L, Wang C, Huang S, Cao X,
Zha R, Liu L, Jia D, Tian Q, Wu J, et al: MicroRNA-148a suppresses
tumor cell invasion and metastasis by downregulating ROCK1 in
gastric cancer. Clin Cancer Res. 17:7574–7583. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Murata T, Takayama K, Katayama S, Urano T,
Horie-Inoue K, Ikeda K, Takahashi S, Kawazu C, Hasegawa A, Ouchi Y,
et al: miR-148a is an androgen-responsive microRNA that promotes
LNCaP prostate cell growth by repressing its target CAND1
expression. Prostate Cancer Prostatic Dis. 13:356–361. 2010.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Bhattacharya S, Chalk AM, Ng AJ, Martin
TJ, Zannettino AC, Purton LE, Lu J, Baker EK and Walkley CR:
Increased miR-155-5p and reduced miR-148a-3p contribute to the
suppression of osteosarcoma cell death. Oncogene. 35:5282–5294.
2016. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yu J, Li Q, Xu Q, Liu L and Jiang B:
MiR-148a inhibits angiogenesis by targeting ERBB3. J Biomed Res.
25:170–177. 2011. View Article : Google Scholar : PubMed/NCBI
|
24
|
Long XR, He Y, Huang C and Li J:
MicroRNA-148a is silenced by hypermethylation and interacts with
DNA methyltransferase 1 in hepatocellular carcinogenesis. Int J
Oncol. 44:1915–1922. 2014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Jiang Q, He M, Ma MT, Wu HZ, Yu ZJ, Guan
S, Jiang LY, Wang Y, Zheng DD, Jin F and Wei MJ: MicroRNA-148a
inhibits breast cancer migration and invasion by directly targeting
WNT-1. Oncol Rep. 35:1425–1432. 2016. View Article : Google Scholar : PubMed/NCBI
|
26
|
Xue J, Chen Z, Gu X, Zhang Y and Zhang W:
MicroRNA-148a inhibits migration of breast cancer cells by
targeting MMP-13. Tumour Biol. 37:1581–1590. 2016. View Article : Google Scholar : PubMed/NCBI
|
27
|
Li J, Song Y, Wang Y, Luo J and Yu W:
MicroRNA-148a suppresses epithelial-to-mesenchymal transition by
targeting ROCK1 in non-small cell lung cancer cells. Mol Cell
Biochem. 380:277–282. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Noguchi S, Mori T, Otsuka Y, Yamada N,
Yasui Y, Iwasaki J, Kumazaki M, Maruo K and Akao Y: Anti-oncogenic
microRNA-203 induces senescence by targeting E2F3 protein in human
melanoma cells. J Biol Chem. 287:11769–11777. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Xiao F, Zhang W, Chen L, Chen F, Xie H,
Xing C, Yu X, Ding S, Chen K, Guo H, et al: MicroRNA-503 inhibits
the G1/S transition by downregulating cyclin D3 and E2F3 in
hepatocellular carcinoma. J Transl Med. 11:1952013. View Article : Google Scholar : PubMed/NCBI
|
30
|
Chang SW, Yue J, Wang BC and Zhang XL:
miR-503 inhibits cell proliferation and induces apoptosis in
colorectal cancer cells by targeting E2F3. Int J Clin Exp Pathol.
8:12853–12860. 2015.PubMed/NCBI
|
31
|
Liu L, Qiu M, Tan G, Liang Z, Qin Y, Chen
L, Chen H and Liu J: miR-200c Inhibits invasion, migration and
proliferation of bladder cancer cells through down-regulation of
BMI-1 and E2F3. J Transl Med. 12:3052014. View Article : Google Scholar : PubMed/NCBI
|